A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg.
Saved in:
| Title: | A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg. |
|---|---|
| Authors: | Biskupska-Bodova, Kristina1,2 (AUTHOR), Sójka-Kupny, Joanna3 (AUTHOR), Nyirády, Tamás4 (AUTHOR), Burke, Anne E.5 (AUTHOR), Angulo, Alicyoy6 (AUTHOR), Regidor, Pedro Antonio7 (AUTHOR) pedro-antonio.regidor@exeltis.com |
| Source: | European Journal of Contraception & Reproductive Health Care. Feb2025, Vol. 30 Issue 1, p3-12. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13625187 |
|---|---|
| DOI: | 10.1080/13625187.2024.2398433 |
